Pyxis Oncology, Inc. (PYXS) Insider Trading -- Recent Executive & Director Transactions
7 insiders reported 10 Form 4 transactions for Pyxis Oncology, Inc. (PYXS) over the past 18 months (most recent 2026-10-02). Recent activity: GordonMD Long Biased GP LLC (10% Owner) Buy 5.5M shares, GordonMD Long Biased Master Fund LP (10% Owner) Buy 5.5M shares, Gordon Craig D (10% Owner) Buy 5.5M shares, GordonMD Global Investments LP (10% Owner) Buy 5.5M shares, Dupont Jakob (Director) Sell 35,000 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-02 | GordonMD Long Biased GP LLC | 10% Owner | Buy | 5.5M | $0 |
| 2026-10-02 | GordonMD Long Biased Master Fund LP | 10% Owner | Buy | 5.5M | $0 |
| 2026-10-02 | Gordon Craig D | 10% Owner | Buy | 5.5M | $0 |
| 2026-10-02 | GordonMD Global Investments LP | 10% Owner | Buy | 5.5M | $0 |
| 2026-07-02 | Dupont Jakob | Director | Sell | 35,000 | $107,100 |
| 2026-07-02 | Dupont Jakob | Director | Buy | 35,000 | $56,000 |
| 2026-03-25 | Wadhane Jitendra | Prin Fin & Acct Officer | Buy | 109,461 | $0 |
| 2026-03-25 | HUMPHREY RACHEL | Director | Sell | 1,400 | $1,358 |
| 2026-03-25 | HUMPHREY RACHEL | Director | Sell | 200 | $194 |
| 2026-03-25 | HUMPHREY RACHEL | Director | Sell | 13,896 | $14,313 |
Source: SEC Form 4 filings · as of 2026-10-02